We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at ...
As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and ...
With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.
Swiss National Bank increased its stake in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) by 34.4% during the 4th ...
Corebridge Financial Inc. lessened its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) ...
Milestone Pharmaceuticals' stock drops over 61% after receiving a Complete Response Letter from the FDA for its CARDAMYST NDA ...
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing ...
Lexicon Pharmaceuticals, Inc.’s LXRX share price has surged by 77.50%, which has investors questioning if this is right time ...
Biotech is an area that may offer your portfolio growth today and earnings stability tomorrow. The idea is a biotech stock ...
Artificial intelligence (AI) is changing the world. Corporations are racing to establish themselves as leaders in the field, ...
Viking Therapeutics seems to be doubling down on its hopes of making waves in the weight management market as a stand-alone ...
Indian equity benchmarks advanced on Thursday, driven by gains in heavyweight financials, although a decline in Tata Motors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results